Thermo Fisher Scientific Debt Repayments increased by 79.4% to $1.41B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 68.5%, from $838.00M to $1.41B. Over 2 years (FY 2023 to FY 2025), Debt Repayments shows a downward trend with a -35.4% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
A decrease may indicate a focus on capital preservation or refinancing, while a significant increase signals active debt reduction or maturity fulfillment.
Represents the total cash outflows used to reduce the principal balance of short-term and long-term debt obligations. Th...
Standard across all capital-intensive industries; peers with high leverage typically show higher repayment activity.
debt_repayment| Q4 '21 | Q1 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $8.94B | $375.00M | $0.00 | $1.00B | $1.00B | $3.78B | $0.00 | $0.00 | $1.11B | $2.50B | $838.00M | $787.00M | $0.00 | $787.00M | $1.41B |
| QoQ Change | — | -95.8% | -100.0% | — | +0.0% | +278.2% | -100.0% | — | — | +125.8% | -66.5% | -6.1% | -100.0% | — | +79.4% |
| YoY Change | — | — | -100.0% | — | — | — | — | -100.0% | +10.7% | -33.9% | — | — | -100.0% | -68.5% | +68.5% |